SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Popular stocks with increasing option volume: SPCX INTC AMC MU WULF PLTR NOK IBM CMG SMCI HOOD AVGO